What are the legal justifications and limits for FDA control over the manufacture, distibution, and sale of leronlimab? They don't have the same level of control over many other health products such as herbal medicines, skin lotions, mouth wash, vitamins, and many commercial products sold over the counter. If CYDY made no specific claim as to efficacy could it legally distribute it as a general health care product until it was proven by adequate data to be effective? Could CYDY offer its product to its share holder owners as a reward for their support? Are there limits to FDA's authority?